Nuvectis Pharma, Inc. NVCT Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s compensation and benefits?
- Nuvectis Pharma, Inc. (NVCT) reported compensation and benefits of $6.45M in Q1 2026.
- How has Nuvectis Pharma, Inc.'s compensation and benefits changed year-over-year?
- Nuvectis Pharma, Inc.'s compensation and benefits increased by 28.0% year-over-year, from $5.04M to $6.45M.
- What is the long-term trend for Nuvectis Pharma, Inc.'s compensation and benefits?
- Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s compensation and benefits has grown at a 164.1% compound annual growth rate (CAGR), from $142K to $6.91M.